Remove Government Remove Management Remove Manufacturing Remove Webinar
article thumbnail

HPM and Riparian to Co-Host Webinar on CMS Misclassification Penalties Rule

FDA Law

(HPM) and Riparian LLC will co-host a webinar on an important CMS rule imposing penalties for misclassification of drugs and other reporting errors under the Medicaid Drug Rebate Program. The Webinar will explore the CMS rule and provide actionable recommendations for manufacturers on how to navigate the new requirements.

article thumbnail

Reminder: HPM and Riparian to Co-Host Webinar on CMS Misclassification Penalties Rule

FDA Law

(HPM) and Riparian LLC will co-host a webinar on an important CMS rule imposing penalties for misclassification of drugs and other reporting errors under the Medicaid Drug Rebate Program. The Webinar will explore the CMS rule and provide actionable recommendations for manufacturers on how to navigate the new requirements.

article thumbnail

Get Up To Speed on Medicare Inflation Rebates: HPM Issues Memorandum Summarizing CMS Final Rule; HPM and Riparian to Co-Host Webinar

FDA Law

Gaulkin Drug manufacturers wont be receiving their first invoices for Medicare Part B and Part D inflation rebates until later this year, but rebates have been accruing since first quarter 2023 for Part B rebates and October 2022 for Part D rebates. The webinar will explore the legal and operational considerations for drug manufacturers.